Efficacy and Safety of IgPro20, a Subcutaneous Immunoglobulin, in Japanese Patients with Primary Immunodeficiency Diseases

PURPOSE: Intravenous (IVIG) and subcutaneous (SCIG) immunoglobulin infusions are widely used for the treatment of patients with primary immunodeficiency (PID) worldwide. This prospective, multicenter, open-label, single-arm Phase III study evaluated the efficacy, tolerability, and safety of IgPro20...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Kanegane, Hirokazu, Imai, Kohsuke, Yamada, Masafumi, Takada, Hidetoshi, Ariga, Tadashi, Bexon, Martin, Rojavin, Mikhail, Hu, Wilson, Kobayashi, Midori, Lawo, John-Philip, Nonoyama, Shigeaki, Hara, Toshiro, Miyawaki, Toshio
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer US 2014
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3937544/
https://ncbi.nlm.nih.gov/pubmed/24504846
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10875-013-9985-z
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia